The purpose of this paper was to determine the effects of storage and extraction method on the recovery of spiked erlotinib from plasma.
Automatic Supported Liquid Extraction (SLE) Coupled with HILIC-MS/MS: An Application to Method Development and Validation of Erlotinib in Human Plasma
Pan J, Jiang X, Chen Y-L
Purpose
Conclusion
Erlotinib concentration in plasma was unaffected by storage at ambient temperatures for 24 h, 3 freeze-thaw cycles, or 227 days at -20 or -70 degrees C. The average erlotinib recovery from plasma was 101.3% when extraction was performed using supported liquid extraction (SLE) with methyl-tert butyl ether (MTBE) rather than protein precipitation (PPT) with acetonitrile-methanol-formic acid or liquid-liquid extraction with MTBE (LLE), which resulted in average recoveries of 73.3 and 83.6%, respectively. Further, after SLE, erlotinib was stable in the autosampler at 4 degrees C for 3 days.
Studies (1)
Purpose
Summary of Findings
Biospecimens
FluidPlasmaPreservation Types
None (Fresh)Diagnoses
NormalPlatforms
Small moleculeHPLC-MSPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Biospecimen components 160 ng/mL erlotinib1600 ng/mL erlotinib6 ng/mL erlotinibStorage Freeze/thaw cycling 0 cycles3 cyclesStorage Storage duration 0 h227 days24 h3 daysStorage Storage temperature -20 degrees C-70 degrees C4 degrees CAmbient temperatureAnalyte Extraction and Purification Analyte isolation method Liquid-liquid extraction with MTBEProtein precipitationSupported liquid extraction with MTBE